Long-term outcomes of prophylactic placement of an endovascular balloon in the vena cava for high-risk transvenous lead extractions

Darren C Tsang; Ryan Azarrafiy; Simon Pecha; Hermann Reichenspurner; Roger G Carrillo; Samer Hakmi

doi:10.1016/j.hrthm.2017.08.003

Long-term outcomes of prophylactic placement of an endovascular balloon in the vena cava for high-risk transvenous lead extractions

Standard

Long-term outcomes of prophylactic placement of an endovascular balloon in the vena cava for high-risk transvenous lead extractions. / Tsang, Darren C; Azarrafiy, Ryan; Pecha, Simon ; Reichenspurner, Hermann; Carrillo, Roger G; Hakmi, Samer.

In: HEART RHYTHM, Vol. 14, No. 12, 12.2017, p. 1833-1838.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Tsang, DC, Azarrafiy, R, Pecha, S , Reichenspurner, H, Carrillo, RG & Hakmi, S 2017, 'Long-term outcomes of prophylactic placement of an endovascular balloon in the vena cava for high-risk transvenous lead extractions', HEART RHYTHM, vol. 14, no. 12, pp. 1833-1838. https://doi.org/10.1016/j.hrthm.2017.08.003

APA

Tsang, D. C., Azarrafiy, R., Pecha, S., Reichenspurner, H., Carrillo, R. G., & Hakmi, S. (2017). Long-term outcomes of prophylactic placement of an endovascular balloon in the vena cava for high-risk transvenous lead extractions. HEART RHYTHM, 14(12), 1833-1838. https://doi.org/10.1016/j.hrthm.2017.08.003

Vancouver

Tsang DC, Azarrafiy R, Pecha S , Reichenspurner H, Carrillo RG, Hakmi S. Long-term outcomes of prophylactic placement of an endovascular balloon in the vena cava for high-risk transvenous lead extractions. HEART RHYTHM. 2017 Dec;14(12):1833-1838. https://doi.org/10.1016/j.hrthm.2017.08.003

Bibtex

@article{58a9a9b49a9e4950bb7d1c6c7efddc03,

title = "Long-term outcomes of prophylactic placement of an endovascular balloon in the vena cava for high-risk transvenous lead extractions",

abstract = "BACKGROUND: Many clinicians use the strategy of prophylactically placing an endovascular balloon before transvenous lead extraction, yet there are no data regarding this practice.OBJECTIVE: This study assesses long-term outcomes of prophylactic placement of an endovascular balloon in the venae cavae of patients during transvenous lead extraction.METHODS: From April 1, 2016 to March 31, 2017 data were prospectively collected at 2 international cardiovascular centers on patients who had the balloon prophylactically placed in the venae cavae. Patients were monitored for a minimum of 3 months to capture any associated adverse events.RESULTS: Twenty-one patients had the balloon prophylactically placed in the venae cavae during lead extraction. Sixteen patients were male (76%); the mean age was 57.6 ± 18.7 years; and the mean body mass index was 26.1 ± 4.4 kg/m2. The mean lead dwell time was 11.2 ± 8.3 years, with an average of 2.2 ± 1.1 leads per case, and most indications for extraction were noninfectious (62%). Two minor complications (10%, pocket hematomas) and 1 major complication (5%, cardiac tamponade) occurred during the procedure. All cases (100%) were procedural successes, and all patients (100%) were discharged alive. On follow-up (6.8 ± 3.7 months), all patients were alive and reported no adverse events related to prophylactic balloon placement, such as pulmonary emboli or deep venous thrombi.CONCLUSION: During the study period, we observed no acute or long-term adverse outcomes associated with prophylactic placement of an endovascular balloon in the venae cavae of patients undergoing transvenous lead extraction.",

keywords = "Catheterization, Peripheral/adverse effects, Defibrillators, Implantable/adverse effects, Device Removal/adverse effects, Endovascular Procedures/methods, Equipment Design, Female, Fluoroscopy, Follow-Up Studies, Germany/epidemiology, Humans, Incidence, Male, Middle Aged, Postoperative Complications/epidemiology, Pulmonary Embolism/diagnostic imaging, Retrospective Studies, Risk Factors, Surgery, Computer-Assisted/methods, Time Factors, United States/epidemiology, Venae Cavae",

author = "Tsang, {Darren C} and Ryan Azarrafiy and Simon Pecha and Hermann Reichenspurner and Carrillo, {Roger G} and Samer Hakmi",

year = "2017",

month = dec,

doi = "10.1016/j.hrthm.2017.08.003",

language = "English",

volume = "14",

pages = "1833--1838",

journal = "HEART RHYTHM",

issn = "1547-5271",

publisher = "Elsevier",

number = "12",

}

RIS

TY - JOUR

T1 - Long-term outcomes of prophylactic placement of an endovascular balloon in the vena cava for high-risk transvenous lead extractions

AU - Tsang, Darren C

AU - Azarrafiy, Ryan

AU - Pecha, Simon

AU - Reichenspurner, Hermann

AU - Carrillo, Roger G

AU - Hakmi, Samer

PY - 2017/12

Y1 - 2017/12

N2 - BACKGROUND: Many clinicians use the strategy of prophylactically placing an endovascular balloon before transvenous lead extraction, yet there are no data regarding this practice.OBJECTIVE: This study assesses long-term outcomes of prophylactic placement of an endovascular balloon in the venae cavae of patients during transvenous lead extraction.METHODS: From April 1, 2016 to March 31, 2017 data were prospectively collected at 2 international cardiovascular centers on patients who had the balloon prophylactically placed in the venae cavae. Patients were monitored for a minimum of 3 months to capture any associated adverse events.RESULTS: Twenty-one patients had the balloon prophylactically placed in the venae cavae during lead extraction. Sixteen patients were male (76%); the mean age was 57.6 ± 18.7 years; and the mean body mass index was 26.1 ± 4.4 kg/m2. The mean lead dwell time was 11.2 ± 8.3 years, with an average of 2.2 ± 1.1 leads per case, and most indications for extraction were noninfectious (62%). Two minor complications (10%, pocket hematomas) and 1 major complication (5%, cardiac tamponade) occurred during the procedure. All cases (100%) were procedural successes, and all patients (100%) were discharged alive. On follow-up (6.8 ± 3.7 months), all patients were alive and reported no adverse events related to prophylactic balloon placement, such as pulmonary emboli or deep venous thrombi.CONCLUSION: During the study period, we observed no acute or long-term adverse outcomes associated with prophylactic placement of an endovascular balloon in the venae cavae of patients undergoing transvenous lead extraction.

AB - BACKGROUND: Many clinicians use the strategy of prophylactically placing an endovascular balloon before transvenous lead extraction, yet there are no data regarding this practice.OBJECTIVE: This study assesses long-term outcomes of prophylactic placement of an endovascular balloon in the venae cavae of patients during transvenous lead extraction.METHODS: From April 1, 2016 to March 31, 2017 data were prospectively collected at 2 international cardiovascular centers on patients who had the balloon prophylactically placed in the venae cavae. Patients were monitored for a minimum of 3 months to capture any associated adverse events.RESULTS: Twenty-one patients had the balloon prophylactically placed in the venae cavae during lead extraction. Sixteen patients were male (76%); the mean age was 57.6 ± 18.7 years; and the mean body mass index was 26.1 ± 4.4 kg/m2. The mean lead dwell time was 11.2 ± 8.3 years, with an average of 2.2 ± 1.1 leads per case, and most indications for extraction were noninfectious (62%). Two minor complications (10%, pocket hematomas) and 1 major complication (5%, cardiac tamponade) occurred during the procedure. All cases (100%) were procedural successes, and all patients (100%) were discharged alive. On follow-up (6.8 ± 3.7 months), all patients were alive and reported no adverse events related to prophylactic balloon placement, such as pulmonary emboli or deep venous thrombi.CONCLUSION: During the study period, we observed no acute or long-term adverse outcomes associated with prophylactic placement of an endovascular balloon in the venae cavae of patients undergoing transvenous lead extraction.

KW - Catheterization, Peripheral/adverse effects

KW - Defibrillators, Implantable/adverse effects

KW - Device Removal/adverse effects

KW - Endovascular Procedures/methods

KW - Equipment Design

KW - Female

KW - Fluoroscopy

KW - Follow-Up Studies

KW - Germany/epidemiology

KW - Humans

KW - Incidence

KW - Male

KW - Middle Aged

KW - Postoperative Complications/epidemiology

KW - Pulmonary Embolism/diagnostic imaging

KW - Retrospective Studies

KW - Risk Factors

KW - Surgery, Computer-Assisted/methods

KW - Time Factors

KW - United States/epidemiology

KW - Venae Cavae

U2 - 10.1016/j.hrthm.2017.08.003

DO - 10.1016/j.hrthm.2017.08.003

M3 - SCORING: Journal article

C2 - 28797678

VL - 14

SP - 1833

EP - 1838

JO - HEART RHYTHM

JF - HEART RHYTHM

SN - 1547-5271

IS - 12

ER -